Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid

4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid is listed in the pharmaceutical impurity collection under CAS 351465-72-0. Its represented structure has formula C16H17NO5 and a calculated molecular weight of 303.31 g/mol.

2D chemical structure

O O H N H O O O H

Chemical identity

Catalog name
4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid
Common name
Not available
Chemical name
4-[[(6-carboxycyclohex-3-ene-1-carbonyl)amino]methyl]benzoic acid
CAS
351465-72-0
SMILES
O=C(O)c1ccc(CNC(=O)C2CC=CCC2C(=O)O)cc1
InChI
InChI=1S/C16H17NO5/c18-14(12-3-1-2-4-13(12)16(21)22)17-9-10-5-7-11(8-6-10)15(19)20/h1-2,5-8,12-13H,3-4,9H2,(H,17,18)(H,19,20)(H,21,22)
InChIKey
KDILGXQBRXISBN-UHFFFAOYSA-N

Record ID: Aeec17f69f500

Computed properties

C16H17NO5 Molecular formula
303.314 g/molMolecular weight
303.1107 DaMonoisotopic exact mass
103.7 ŲTopological polar surface area
1.668 Calculated LogP (Wildman–Crippen)
78.2378 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
3 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD. 2 potential atom stereocenters have unspecified configuration.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H N O 0 4 8 12 16 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight303.31445.22
Calculated LogP (Wildman–Crippen)1.66836.43
Topological polar surface area103.774.08
Hydrogen-bond acceptors333.13
Hydrogen-bond donors381.39
Rotatable bonds (strict)560.59

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC16H17NO5dimensionless
Molecular weight303.314g/mol
Monoisotopic exact mass303.1107Da
Topological polar surface area103.7Ų
Calculated LogP (Wildman–Crippen)1.668dimensionless
Molar refractivity (Wildman–Crippen)78.2378cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors3count
Rotatable bonds (strict)5count
Heavy atoms22count
Heteroatoms6count
Rings2count
Aromatic rings1count
Aliphatic rings1count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles1count
Fraction of sp³ carbon atoms0.3125fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters2count
Unspecified atom stereocenters2count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area127.0083Ų
Valence electrons116count
Radical electrons0count
Bertz complexity605.4671index
Balaban J1.9526index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid

Qualification and safety assessment of 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid

Explore toxicological qualification of 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid and ICH M7 mutagenic impurity assessment of 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid and acceptable intake and limit justification for 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 4-{[(6-carboxycyclohexyl-3-en-1-yl) carbonyl] amino] methylbenzoic acid

Explore Altox services and software through the Altox Pharma-Hub.